Cargando…

Comparison of survival outcomes between primary and secondary muscle-invasive bladder cancer: An updated meta-analysis

Objective: Studies have showed that different follow-up starting points might potentially impact the comparison between primary (PMIBC) and secondary muscle-invasive bladder cancer (SMIBC), but the only previous meta-analysis did not differentiate the follow-up starting points of included studies. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Xiaonan, Qiu, Shi, Yang, Lu, Wei, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757133/ https://www.ncbi.nlm.nih.gov/pubmed/33390819 http://dx.doi.org/10.7150/ijms.49228

Ejemplares similares

Comparison of the survival outcomes between primary and secondary muscle-invasive bladder cancer: a propensity score-matched study
por: Lok, Waichan, et al.
Publicado: (2023)

Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
por: Zhou, Xianghong, et al.
Publicado: (2020)

Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis
por: Ge, Peng, et al.
Publicado: (2018)

LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Pones, Mario, et al.
Publicado: (2021)

The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Zheng, Weitao, et al.
Publicado: (2022)

Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database
por: Jin, Kun, et al.
Publicado: (2021)

Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer
por: Byun, Sang Jun, et al.
Publicado: (2015)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

The natural history of secondary muscle-invasive bladder cancer
por: Hidas, Guy, et al.
Publicado: (2013)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
por: D'Andrea, David, et al.
Publicado: (2022)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

“Primary” and “secondary” muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes
por: Pietzak, Eugene J., et al.
Publicado: (2019)

Meta-analysis of microRNAs as biomarkers for muscle-invasive bladder cancer
por: Zheng, Lin-Feng, et al.
Publicado: (2016)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

Therapeutic Outcome of Fluorescence Cystoscopy Guided Transurethral Resection in Patients with Non-Muscle Invasive Bladder Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Yuan, Haichao, et al.
Publicado: (2013)

Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer
por: Myint, Zin W., et al.
Publicado: (2023)

Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
por: Szarvas, Tibor, et al.
Publicado: (2019)

High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer
por: Shi, Ming-Jun, et al.
Publicado: (2019)

Surviving travel or travelling to survive: the association of travel distance with survival in muscle invasive bladder cancer
por: Kim, Albert H., et al.
Publicado: (2018)

Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms
por: Mizusawa, Hiroya, et al.
Publicado: (2021)

AB007. Bladder-sparing treatments for muscle-invasive bladder cancer
por: Li, Shengwen, et al.
Publicado: (2017)

The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer
por: Miyata, Haruka, et al.
Publicado: (2020)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy
por: Hu, Bing, et al.
Publicado: (2023)

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)

Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer
por: De Carlo, Camilla, et al.
Publicado: (2022)

Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer
por: Li, Shuaishuai, et al.
Publicado: (2022)

Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment
por: Bejrananda, Tanan, et al.
Publicado: (2022)

Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer
por: Sanguedolce, Francesca, et al.
Publicado: (2023)

STAG2 Expression is Associated with Adverse Survival Outcomes and Regulates Cell Phenotype in Muscle-invasive Bladder Cancer
por: Athans, Sarah R., et al.
Publicado: (2022)

Comparison of Laparoscopic and Open Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Lisiński, Janusz, et al.
Publicado: (2022)

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
por: Tan, Wei Shen, et al.
Publicado: (2023)

Update on the management of invasive bladder cancer 2012
por: Goethuys, Hans, et al.
Publicado: (2012)

Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis
por: Qiu, Junlan, et al.
Publicado: (2022)

Diagnostic value of Xpert(®) Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update
por: D’Elia, Carolina, et al.
Publicado: (2021)

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis
por: Schuettfort, Victor M., et al.
Publicado: (2020)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches
por: Xie, Weibin, et al.
Publicado: (2020)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v1absol5sm9ok63pp4ooj8tc04